Lannett CDMO

Lannett Company, Inc., founded in 1942, is a well-established manufacturer of unique pharmaceutical indications.

With a rich history spanning over 75 years, Lannett CDMO has established itself as a trusted partner in the pharmaceutical industry. Our dedicated manufacturing site in Seymour, Indiana, spans 30 acres and boasts a track record of delivering high-quality oral solid doses and liquid finished products to clients worldwide.

Our team of experienced professionals has successfully brought over 100 unique pharmaceutical products to market. With a strong focus on quality, on-time delivery, and schedule attainment, we're committed to helping you accelerate your time to market.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Product Formulation (FDF);Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

High Potent Products capabilities:

OEB 3;OEB 4-5

Facilities Locations:

North America

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);ISO;GMP;PMDA (Japan);Health Canada

Manufacturing Technologies:

Liquids;Semi-solids;Solids

Current Capacity:

2.5 Billion OSD units and 1.0 Billion Liters of Liquids

Lannett CDMO is committed to providing top-quality contract development and manufacturing services to the pharmaceutical industry. For more information, please visit lannett.com.

Certification

United States FDA, Europe EMA, GMP, China NMPA, Canada Health Canada